The Structural Formula For Budesonide (Image 1)
Budesonide Tablet, Film Coated, Extended Release
Product Images NDC 0591-2510
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 0591-2510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ndc 0591-2510-30 (Image 2)
This is a medication package for Budesonide Extended-Release Tablets with each extended-release tablet containing 9mg of Budesonide, USP. The tablets should not be chewed, crushed, or broken and must be swallowed whole. The container should be kept tightly closed, protected from moisture and light, and stored at room temperature. The package insert provides information on ingredients along with dosage details. The standard dosage for this medication is one tablet a day, and it is recommended to keep the medication out of the reach of children. The package was manufactured by Actavis Laboratories, and it is distributed by Actavi Pharms, Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
